Werner Syndrome: Clinical Trials

4 trials for Werner Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting. 2 Phase 1, 2 Phase 2, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Recruiting 1
Phase 22Recruiting 2
Not applicable1Completed 1

Follow Werner Syndrome: new trials by email Literature Review of Werner Syndrome trials Research Report on Werner Syndrome

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 2, Open-Label Study to Evaluate the Safety and Tolerability of Progerinin in Werner Syndrome
Progerinin - Werner Syndrome
Phase 2RecruitingPRG Science & Technology Co., Ltd.52026-10-012026-10-05
A Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients With Advanced Solid Tumors.
NDI-219216 - Advanced Solid Tumors Cancer, MSI-H Cancer
Phase 1 / Phase 2RecruitingNimbus Wadjet, Inc.1342025-03-312026-05-06
Phase I Study of Progerinin in Healthy Volunteers
Progerinin, Placebo - Hutchinson-Gilford Progeria Syndrome, Werner Syndrome
Phase 1CompletedPRG Science & Technology Co., Ltd.642020-08-242021-09-22
Descriptive Study of Recombinant Human Insulin-Like Growth Factor for Osteoporosis in Werner's Syndrome
growth hormone - Werner's Syndrome
Not applicableCompletedNational Center for Research Resources (NCRR)11992-05-012005-06-24

Narrower conditions

Genetic Diseases, Inborn (1)  ·  Microsatellite Instability (1)  ·  Progeria (1)  ·  Rare Diseases (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4)  ·  DNA Repair-Deficiency Disorders (4)  ·  Metabolic Diseases (4)  ·  Nutritional and Metabolic Diseases (4)  ·  Genetic Diseases, Inborn (3)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Disease Attributes (1)  ·  Genomic Instability (1)  ·  Laminopathies (1)  ·  Metabolism, Inborn Errors (1)

Interventions

Growth Hormone (1)

Sponsors

PRG Science & Technology Co., Ltd. (2)  ·  National Center for Research Resources (NCRR) (1)  ·  Nimbus Wadjet, Inc. (1)

Countries

United States (3)  ·  Australia (1)  ·  Canada (1)  ·  France (1)  ·  Ireland (1)  ·  Portugal (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Anita Scheuber, MD, PhD (1)  ·  Craig D. Rubin (1)